Search stocks

Find any stock by ticker or company name

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Kuzatuv
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

SBS - Companhia de Saneamento Básico do... | Finranks

Home

/

SBS

C

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS)

NYQ – Real vaqt narxi. Valyuta: USD

6.04

-0.22 (-3.51%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

4 Stocks to Watch From the Challenging Water Supply Industry

4 Stocks to Watch From the Challenging Water Supply Industry

Water utilities like SBS, AWR, AWK and CWT are supported by strategic capital investment plans and strong customer bases, positioning them to outperform peers despite persistent challenges facing the water industry.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q1 2026 Earnings Call Transcript

Stratec Q1 Earnings Call Highlights

Stratec Q1 Earnings Call Highlights

Stratec ETR: SBS reported a soft start to fiscal 2026, with first-quarter revenue and adjusted earnings down from the prior-year period, but management reaffirmed its full-year guidance and said visibility into second-half demand has improved.

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f.

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

LONDON, NEW YORK & LISBON, Portugal--(BUSINESS WIRE)-- #LegalTech--Stella Legal and SBS unite to launch a tech-first operating model. It optimizes in-house legal departments via data-driven "Performance Intelligence.".

Sabesp: A New Privatization As An Opportunity!

Sabesp: A New Privatization As An Opportunity!

Sabesp remains a buy, as its potential Copasa acquisition could be a game-changing catalyst, enhancing its investment thesis. SBS's privatization has driven significant efficiency gains, cost reductions, and a record-high EV/EBITDA multiple, reflecting strong management execution. Acquiring a 30% stake in Copasa would add nearly 10% to SBS's EBITDA, with further upside from operational synergies and a possible 27% valuation re-rating.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Analyst/Investor Day Transcript

Videolar

No Data

There is no data to display

Press-relizlar

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, announced today that the company will present data from its LANDMARK survey during the 2026 Digestive Disease Week® (DDW) meeting being held from May 2-5 in Chicago, IL. The data will spotlight healthcare professional (HCP) insights on the burden of total parenteral nutrition (TPN) f.

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

Stella Legal Unites with CSB, Strategic Business Solutions (SBS) To Build Mission Control for Modern Legal Departments

LONDON, NEW YORK & LISBON, Portugal--(BUSINESS WIRE)-- #LegalTech--Stella Legal and SBS unite to launch a tech-first operating model. It optimizes in-house legal departments via data-driven "Performance Intelligence.".